Computational determination of toxicity risks associated with a selection of approved drugs having demonstrated activity against COVID-19

BACKGROUND: The emergence and rapid spread of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) in thelate 2019 has caused a devastating global pandemic of the severe pneumonia-like disease coronavirus disease 2019 (COVID-19). Although vaccines have been and are being developed, they are...

Descripción completa

Detalles Bibliográficos
Autores principales: Aminpour, Maral, Delgado, Williams Ernesto Miranda, Wacker, Soren, Noskov, Sergey, Houghton, Michael, Tyrrell, D. Lorne J., Tuszynski, Jack A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529228/
https://www.ncbi.nlm.nih.gov/pubmed/34674775
http://dx.doi.org/10.1186/s40360-021-00519-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529228/
https://www.ncbi.nlm.nih.gov/pubmed/34674775
http://dx.doi.org/10.1186/s40360-021-00519-5

Ejemplares similares